Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs PARABOLIC DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB PARABOLIC DRUGS DR. REDDYS LAB/
PARABOLIC DRUGS
 
P/E (TTM) x 17.6 -1.8 - View Chart
P/BV x 4.2 - - View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DR. REDDYS LAB   PARABOLIC DRUGS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
PARABOLIC DRUGS
Mar-18
DR. REDDYS LAB/
PARABOLIC DRUGS
5-Yr Chart
Click to enlarge
High Rs4,65610 47,461.3%   
Low Rs3,7886 62,916.1%   
Sales per share (Unadj.) Rs1,481.411.8 12,532.5%  
Earnings per share (Unadj.) Rs270.7-9.3 -2,910.8%  
Cash flow per share (Unadj.) Rs345.7-5.8 -5,950.3%  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs1,389.6-142.4 -975.8%  
Shares outstanding (eoy) m166.5361.89 269.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.80.7 425.6%   
Avg P/E ratio x15.6-0.9 -1,832.3%  
P/CF ratio (eoy) x12.2-1.4 -896.4%  
Price / Book Value ratio x3.0-0.1 -5,466.0%  
Dividend payout %14.80-   
Avg Mkt Cap Rs m703,039490 143,514.0%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46698 47,250.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697732 33,721.6%  
Other income Rs m10,55542 25,378.7%   
Total revenues Rs m257,252773 33,272.8%   
Gross profit Rs m63,860-291 -21,974.5%  
Depreciation Rs m12,502216 5,791.2%   
Interest Rs m1,42893 1,535.8%   
Profit before tax Rs m60,485-558 -10,841.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,41218 87,568.2%   
Profit after tax Rs m45,073-575 -7,832.2%  
Gross profit margin %25.9-39.7 -65.2%  
Effective tax rate %25.5-3.2 -807.7%   
Net profit margin %18.3-78.7 -23.2%  
BALANCE SHEET DATA
Current assets Rs m203,161737 27,555.8%   
Current liabilities Rs m85,7213,942 2,174.5%   
Net working cap to sales %47.6-438.1 -10.9%  
Current ratio x2.40.2 1,267.2%  
Inventory Days Days791 11,182.7%  
Debtors Days Days107144 74.6%  
Net fixed assets Rs m112,6383,330 3,382.2%   
Share capital Rs m833619 134.6%   
"Free" reserves Rs m230,571-9,432 -2,444.5%   
Net worth Rs m231,404-8,813 -2,625.6%   
Long term debt Rs m1,2788,352 15.3%   
Total assets Rs m315,7994,089 7,722.4%  
Interest coverage x43.4-5.0 -867.1%   
Debt to equity ratio x0-0.9 -0.6%  
Sales to assets ratio x0.80.2 436.7%   
Return on assets %14.7-11.8 -124.8%  
Return on equity %19.56.5 298.3%  
Return on capital %26.6100.9 26.4%  
Exports to sales %52.222.0 237.4%   
Imports to sales %16.82.6 645.1%   
Exports (fob) Rs m128,803161 80,051.6%   
Imports (cif) Rs m41,48419 217,535.4%   
Fx inflow Rs m128,803161 80,051.6%   
Fx outflow Rs m41,48420 207,627.6%   
Net fx Rs m87,319141 61,963.5%   
CASH FLOW
From Operations Rs m58,87531 191,962.8%  
From Investments Rs m-41,3739 -479,409.0%  
From Financial Activity Rs m-26,861-37 72,538.5%  
Net Cashflow Rs m-9,0732 -399,691.6%  

Share Holding

Indian Promoters % 26.7 37.1 71.9%  
Foreign collaborators % 0.0 0.7 -  
Indian inst/Mut Fund % 47.4 8.6 549.1%  
FIIs % 29.1 8.1 361.4%  
ADR/GDR % 15.4 0.0 -  
Free float % 58.0 62.2 93.2%  
Shareholders   255,500 13,652 1,871.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs PARABOLIC DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs PARABOLIC DRUGS Share Price Performance

Period Dr. Reddys PARABOLIC DRUGS S&P BSE HEALTHCARE
1-Day 1.59% -4.84% 0.35%
1-Month -2.37% 26.11% 3.05%
1-Year 31.79% 141.53% 55.46%
3-Year CAGR 3.66% -11.38% 13.36%
5-Year CAGR 17.17% -6.58% 21.95%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the PARABOLIC DRUGS share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of PARABOLIC DRUGS the stake stands at 37.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of PARABOLIC DRUGS.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

PARABOLIC DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of PARABOLIC DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Suzlon's New Order Win | Paytm to Exit Postpaid Loans | Top Buzzing Stocks Today Suzlon's New Order Win | Paytm to Exit Postpaid Loans | Top Buzzing Stocks Today(Pre-Open)

Indian share turned positive as the session progressed and ended the day higher.